SCOPUS 정보 검색 플랫폼

Volumn 120, Issue 12, 2012, Pages 2351-2352

MYC addiction: A potential therapeutic target in MM

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MYC INHIBITOR; MYC PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER SURVIVAL; CELL SURVIVAL; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 84866544780 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2012-08-445262 Document Type: Note

Times cited : (48)

References (11)

1
- 84866552319
- Addiction to c-MYC in multiple myeloma
- Holien T, Våtsveen TK, Hella H, Waage A, Sundan A. Addiction to c-MYC in multiple myeloma. Blood. 2012;120(12):2450-2453.
- (2012) Blood , vol.120 , Issue.12 , pp. 2450-2453
- Holien, T.¹ Våtsveen, T.K.² Hella, H.³ Waage, A.⁴ Sundan, A.⁵

2
- 84859171807
- Myc on the path to cancer
- Dang CV. Myc on the path to cancer. Cell. 2012;149(1):22-35.
- (2012) Cell , vol.149 , Issue.1 , pp. 22-35
- Dang, C.V.¹

3
- 75849131117
- The ups and downs of Myc biology
- Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genet Dev. 2010;20(1):91-95.
- (2010) Curr Opin Genet Dev , vol.20 , Issue.1 , pp. 91-95
- Soucek, L.¹ Evan, G.I.²

4
- 79958095463
- Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
- Chng WJ, Huang GF, Chung TH, et al. Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia. 2011;25(6):1026-1035.
- (2011) Leukemia , vol.25 , Issue.6 , pp. 1026-1035
- Chng, W.J.¹ Huang, G.F.² Chung, T.H.³

5
- 52149094341
- Characterization of MYC translocations in multiple myeloma cell lines
- Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM. Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst Monogr. 2008(39):25-31.
- (2008) J Natl Cancer Inst Monogr , Issue.39 , pp. 25-31
- Dib, A.¹ Gabrea, A.² Glebov, O.K.³ Bergsagel, P.L.⁴ Kuehl, W.M.⁵

6
- 78650981573
- Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma
- Zingone A, Kuehl WM. Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma. Semin Hematol. 2011;48(1):4-12.
- (2011) Semin Hematol , vol.48 , Issue.1 , pp. 4-12
- Zingone, A.¹ Kuehl, W.M.²

8
- 80052955256
- BET bromodomain inhibition as a therapeutic strategy to target c-Myc
- Delmore JE, Issa GC, Lemieux ME, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146(6):904-917.
- (2011) Cell , vol.146 , Issue.6 , pp. 904-917
- Delmore, J.E.¹ Issa, G.C.² Lemieux, M.E.³

9
- 80053651202
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- Mertz JA, Conery AR, Bryant BM, et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A. 2011;108(40):16669- 16674.
- (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.40 , pp. 16669-16674
- Mertz, J.A.¹ Conery, A.R.² Bryant, B.M.³

10
- 80055000824
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- Zuber J, Shi J, Wang E, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478(7370):524-528.
- (2011) Nature , vol.478 , Issue.7370 , pp. 524-528
- Zuber, J.¹ Shi, J.² Wang, E.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.